| Supplemental Disclosure of Cash Flow Information |
Note 14 – Supplemental Disclosure
of Cash Flow Information
The supplemental cash flow information
for the six months ended June 30, 2018 and 2017 (unaudited) is as follows:
| |
|
Six Months Ended June 30, |
|
| |
|
2018 |
|
|
2017 |
|
| Cash paid for interest |
|
$ |
18,894 |
|
|
$ |
976,984 |
|
| Cash paid for income taxes |
|
$ |
- |
|
|
$ |
401,313 |
|
| |
|
|
|
|
|
|
|
|
| Acquisition of Jamestown Regional Medical Center: |
|
|
|
|
|
|
|
|
| Cash |
|
$ |
375 |
|
|
$ |
- |
|
| Inventory |
|
$ |
450,682 |
|
|
$ |
- |
|
| Prepaid expenses and other current assets |
|
$ |
310,384 |
|
|
$ |
- |
|
| Property and equipment |
|
$ |
7,347,467 |
|
|
$ |
- |
|
| Intangible Assets |
|
$ |
452,455 |
|
|
$ |
- |
|
| Accrued expenses |
|
$ |
(193,966 |
) |
|
$ |
- |
|
| |
|
|
|
|
|
|
|
|
| Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
| Exchange of preferred stock for convertible debentures and warrants |
|
$ |
- |
|
|
$ |
4,490,760 |
|
| Cashless exercise of warrants |
|
$ |
3,957,766 |
|
|
$ |
- |
|
| Exchange of convertible debentures for convertible debentures and warrants |
|
$ |
- |
|
|
$ |
2,464,500 |
|
| Exchange of debentures into Series I-2 Preferred Stock |
|
$ |
1,384,556 |
|
|
$ |
- |
|
| Note payable and warrants settled through issuance of common stock |
|
$ |
- |
|
|
$ |
440,000 |
|
| Exchange of Series H Preferred Stock for debentures |
|
$ |
- |
|
|
$ |
2,174,000 |
|
| Debentures converted into common stock |
|
$ |
7,093,763 |
|
|
$ |
2,651,236 |
|
| OID from issuance of debentures |
|
$ |
1,310,000 |
|
|
$ |
3,080,200 |
|
| Conversions of shares of Preferred Stock for common stock |
|
$ |
|
|
|
$ |
7,785,000 |
|
| Conversions of shares of Series H Preferred Stock for common stock |
|
$ |
200,000 |
|
|
$ |
|
|
| Deemed dividend for trigger of down round provision feature |
|
$ |
- |
|
|
$ |
51,061,339 |
|
|